Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 901 AL 915

The mechanisms underlying TDP-43-associated neurodegeneration in Alzheimer's disease and related dementias

Gao J, Ding M, Qin S, Shukla D, Vicuna L, Liang J, Wang X.

Mol Psychiatry. 2025 Nov;30(11):5500-5512. doi: 10.1038/s41380-025-03089-8. Epub 2025 Jun 25.

A Retrospective Study of the Association between Low Vitamin B1 in the Blood and Cognitive Impairment in Patients with Alzheimer's Disease

Higaki Y, Kobayashi Y.

J Nutr Sci Vitaminol (Tokyo). 2025;71(5):421-426. doi: 10.3177/jnsv.71.421.

Efficacy of Add-On Agomelatine on Agitation, Aggression, and Neuroprotection in Alzheimer's Disease: A Randomized, Blinded, Controlled Trial

Kargar A, Fetratjoo DH, Moattar R, Tarki A, Golsokhan A, Pouyan N, Amjadi-Goojgi Z, Mostafaei H, Kakeri F, Zendehbad AS, Lima BS, Esmaily H, Noroozian M.

Am J Geriatr Psychiatry. 2025 Aug;33(8):819-834. doi: 10.1016/j.jagp.2025.03.001. Epub 2025 Mar 20.

Hippocampal volume asymmetry in Alzheimer disease: A systematic review and meta-analysis

Pusparani Y, Lin CY, Jan YK, Lin FY, Liau BY, Alex JSR, Aparajeeta J, Chao WH, Lung CW.

Medicine (Baltimore). 2025 Mar 7;104(10):e41662. doi: 10.1097/MD.0000000000041662.

The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study

Chun H, Yoon ML, Lee HW, Lee JY, Hong SB, Ha SS, Yoon KJ.

Photobiomodul Photomed Laser Surg. 2025 Sep;43(9):411-416. doi: 10.1177/15578550251369575.

Neuropsychiatric symptoms and neuroimaging-based brain age in mild cognitive impairment and early dementia: A multicenter study

Sone D, Beheshti I, Tagai K, Kameyama H, Takasaki E, Kashibayashi T, Takahashi R, Ishii K, Kanemoto H, Ikeda M, Shigeta M, Shinagawa S, Kazui H.

Psychiatry Clin Neurosci. 2025 Apr;79(4):158-164. doi: 10.1111/pcn.13777. Epub 2025 Jan 17.

Total and Structural Carotid Artery Stiffness Are Associated With Cognitive Decline and Structural Brain Abnormalities Related to Alzheimer Disease and Alzheimer Disease-Related Dementias Pathology: The Multi-Ethnic Study of Atherosclerosis

Williams JR, DeConne TM, Pewowaruk R, Korcarz C, Tanley J, Carlsson C, Heckbert SR, Habes M, Nasrallah I, Lockhart SN, Luchsinger JA, Ding J, Hayden KM, Hughes TM, Gepner AD.

J Am Heart Assoc. 2025 May 6;14(9):e039925. doi: 10.1161/JAHA.124.039925. Epub 2025 May 2.

High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial

LoBue C, Chiang HS, Salter A, McClintock S, Nguyen TP, Logan R, Smernoff E, Pandya S, Hart J.

J Prev Alzheimers Dis. 2025 Feb;12(2):100023. doi: 10.1016/j.tjpad.2024.100023. Epub 2025 Jan 1.

A meta-analysis and systematic review of interventions to prevent or treat cognitive decline related to Alzheimer's disease in adults with Down syndrome

Munn EE, Montelongo A, Patel VK, Fodstad JC, Ciccarelli MR, Ptomey LT, Pangelinan MM.

Alzheimers Dement. 2025 Jul;21(7):e70471. doi: 10.1002/alz.70471.

The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial

Zuschnegg J, Ropele S, Opriessnig P, Schmidt R, Russegger S, Fellner M, Leitner M, Spat S, Garcia ML, Strobl B, Ploder K, Pszeida M, Hofmarcher-Holzhacker MM, Stoegerer-Oberschmid E, Guttmann-Lattmanig A, Paletta L, Schüssler S, Koini M.

PLoS One. 2025 Aug 13;20(8):e0329931. doi: 10.1371/journal.pone.0329931. eCollection 2025.

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Albertyn CP, Guu TW, Chu P, Creese B, Young A, Velayudhan L, Bhattacharyya S, Jafari H, Kaur S, Kandangwa P, Carter B, Aarsland D.

Age Ageing. 2025 May 31;54(6):afaf149. doi: 10.1093/ageing/afaf149.

Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer's disease

Stroud J, Cummings JL, Chumki SR, Such P, Wang D, Palma AM, Zhang Z, Brubaker M, Grossberg GT.

Curr Med Res Opin. 2025 Aug;41(8):1523-1534. doi: 10.1080/03007995.2025.2552278. Epub 2025 Sep 5.

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada Rovira M, Doraiswamy PM, Liang E, Flint S, Kesslak JP, McLaine R, Albayrak A, Schaefer J, Yu J, Tolar L, Dickson S, Hey JA, Tolar M.

Drugs. 2025 Nov;85(11):1455-1472. doi: 10.1007/s40265-025-02250-5. Epub 2025 Sep 28.

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial

Shah A, Estilo A, Sheridan PL, Kalu U, Chen D, Chang D, Slomkowski M, Lee D, Hefting N, Hobart M, Behl S, Such P, Brubaker M, Grossberg GT.

CNS Drugs. 2025 Oct;39(10):1011-1023. doi: 10.1007/s40263-025-01200-9. Epub 2025 Jul 19.

Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study

Lin M, Zeng Q, Zhong S, Nie S, Zhang R, Hong H, Liu L, Wang S, Li K, Luo X, Chen Y, Huang P; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2025 Dec 23;105(12):e213953. doi: 10.1212/WNL.0000000000213953. Epub 2025 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias